138 related articles for article (PubMed ID: 35651922)
1. Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis.
Yu J; Gao G; Wang J; Zhao J; Zhang Y; Jiang D; Huang F
Comput Math Methods Med; 2022; 2022():4835417. PubMed ID: 35651922
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
[TBL] [Abstract][Full Text] [Related]
3. Loss of 5-hydroxymethylcytosine immunohistochemical expression is a useful diagnostic aid for distinguishing hepatocellular carcinoma in cytology fine needle aspiration specimens.
Zhu X; Dresser K; Chen BJ
Cytopathology; 2019 Sep; 30(5):492-498. PubMed ID: 31081979
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
5. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
6. Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma.
Liu J; Jiang J; Mo J; Liu D; Cao D; Wang H; He Y; Wang H
Hepatology; 2019 Jan; 69(1):196-208. PubMed ID: 30070373
[TBL] [Abstract][Full Text] [Related]
7. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
8. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
9. Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning.
Chen S; Zhang Z; Wang Y; Fang M; Zhou J; Li Y; Dai E; Feng Z; Wang H; Yang Z; Li Y; Huang X; Jia J; Li S; Huang C; Tong L; Xiao X; He Y; Duan Y; Zhu S; Gao C
J Infect Dis; 2021 Jun; 223(11):1887-1896. PubMed ID: 33049037
[TBL] [Abstract][Full Text] [Related]
10. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.
Bai X; Jia JA; Fang M; Chen S; Liang X; Zhu S; Zhang S; Feng J; Sun F; Gao C
PLoS Genet; 2018 Feb; 14(2):e1007206. PubMed ID: 29474353
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
[TBL] [Abstract][Full Text] [Related]
12. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatocellular carcinoma at the miRNA level.
Zhang ZZ; Liu X; Wang DQ; Teng MK; Niu LW; Huang AL; Liang Z
World J Gastroenterol; 2011 Jul; 17(28):3353-8. PubMed ID: 21876625
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
15. Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy.
Kim JH; Kim YD; Lee M; Jun BG; Kim TS; Suk KT; Kang SH; Kim MY; Cheon GJ; Kim DJ; Baik SK; Choi DH
J Hepatol; 2018 Nov; 69(5):1066-1073. PubMed ID: 30075230
[TBL] [Abstract][Full Text] [Related]
16. Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma.
Jia JA; Zhang S; Bai X; Fang M; Chen S; Liang X; Zhu S; Wong DK; Zhang A; Feng J; Sun F; Gao C
Virol J; 2022 Jun; 19(1):114. PubMed ID: 35765099
[TBL] [Abstract][Full Text] [Related]
17. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
18. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
19. RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study.
Said EM; Salem AA; Shousha HI; Ahmad ES; Alazzouny MA; Ahmed IA; Elfeky HM; Abdelsalam FM
Arab J Gastroenterol; 2022 Aug; 23(3):201-205. PubMed ID: 35941073
[TBL] [Abstract][Full Text] [Related]
20. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
J Hepatol; 2016 Jul; 65(1):48-56. PubMed ID: 27034253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
